Abstract:Naturally occurring pentacyclic triterpenes, such as betulinic acid (BA) and its derivatives, exhibit various pharmaceutical activities and have been the subject of great interest, in particular for their antiviral properties. Here, we found a new anti-influenza virus conjugate, hexakis 6-deoxy-6-[4-N-(3β-hydroxy-lup-20(29)-en-28-oate)aminomethyl-1H-1,2,3-triazol-1-yl]-2,3-di-O-acetyl-α-cyclodextrin (CYY1-11, 1), in a mini library of pentacyclic triterpene–cyclodextrin conjugates by performing a cell-based screening assay and then exploring the underlying mechanisms. Our results showed that conjugate 1 possessed a high-level activity against the influenza virus A/WSN/33 with an IC50 value of 5.20 μM (SI > 38.4). The study of the mechanism of action indicated that conjugate 1 inhibited viral replication by directly targeting the influenza hemagglutinin protein (KD = 1.50 μM), thus efficiently preventing the attachment of the virion to its receptors on host cells and subsequent infection. This study suggests that multivalent BA derivatives have possible use as a new class of influenza virus entry inhibitors.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.molpharmaceut.0c00244?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c00244</a>.Effects of conjugate 1 on later viral life cycle processes after the attachment of influenza virus; interaction of BA with influenza HA protein; synthesis process of the two building blocks: hexakis 6-deoxy-6-azide-2,3-di-O-acetyl-α-CD 4 and N-propargyl-3β-hydroxy-lup-20(29)-en-28-amide 7; and 1H NMR, 13C NMR, DPET135, 1H–13C HSQC, and MALDI-TOF MS of conjugate 1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.molpharmaceut.0c00244/suppl_file/mp0c00244_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Polyvalent Effect Enhances Anti-influenza Virus Activity

Glycopolymer with Sulfated Fucose and 6'-Sialyllactose as a Dual-Targeted Inhibitor on Resistant Influenza A Virus Strains

Divalent Oseltamivir Analogues As Potent Influenza Neuraminidase Inhibitors.

Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect.

Synthesis, Structure Activity Relationship and in Vitro Anti-Influenza Virus Activity of Novel Polyphenol-Pentacyclic Triterpene Conjugates.

Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection

Nine-valent oleanolic acid conjugates as potent inhibitors blocking the entry of influenza A virus

Synthesis of C-4-modified Zanamivir Analogs As Neuraminidase Inhibitors and Their Anti-Aiv Activities

Discovery of Aryl Benzoyl Hydrazide Derivatives As Novel Potent Broad-Spectrum Inhibitors of Influenza A Virus RNA-Dependent RNA Polymerase (Rdrp)

Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives

Identification of a Small-Molecule Inhibitor of Influenza Virus Via Disrupting the Subunits Interaction of the Viral Polymerase.

Synthesis of a Hexavalent Betulinic Acid Derivative as a Hemagglutinin-Targeted Influenza Virus Entry Inhibitor

Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.

Design, Synthesis And Biological Activity Evaluation Of Novel Conjugated Sialic Acid And Pentacyclic Triterpene Derivatives As Anti-Influenza Entry Inhibitors

Design, Synthesis and Biological Evaluation of Amino Acids-Oleanolic Acid Conjugates As Influenza Virus Inhibitors.

Conjugating drug candidates to polymeric chains does not necessarily enhance anti-influenza activity

Structure-based methoxyflavone derivatives with potent inhibitory activity against various influenza neuraminidases

Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles

Design,Synthesis and Anti-influenza Activities of Novel Neuraminidase Inhibitors

Rational Design and Optimization of Acylthioureas As Novel Potent Influenza Virus Non-Nucleoside Polymerase Inhibitors.

Synthesis and Structure-Activity Optimization of 7-Azaindoles Containing Aza-Β-amino Acids Targeting the Influenza PB2 Subunit.